UMGCC Paul Calabresi Clinical Oncology Training Program

UMGCC Paul Calabresi 临床肿瘤学培训计划

• 批准号: 7683191
• 负责人: EDWARD A. SAUSVILLE
• 金额: $ 70.81万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-05 至 2013-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7683191
• 关键词: Advisory Committees; Antineoplastic Agents; Applications Grants; Appointment; Area; Award; Baltimore; Bioinformatics; Biometry; Cancer Center; Clinical; Clinical Drug Development; Clinical Oncology; Clinical Protocols; Clinical Research; Clinical Trials; Combined Modality Therapy; Commit; Committee Members; Critiques; Data; Dental Assistants; Development; Doctor of Medicine; Doctor of Philosophy; Educational Curriculum; Environment; Faculty; Figs - dietary; Funding; Goals; K-Series Research Career Programs; Laws; Lead; Learning; Maryland; Master of Science; Master' s Degree; Medical; Mentors; Mentorship; NCI Scholars Program; Peer Review; Pharmacy facility; Population; Population Sciences; Postdoctoral Fellow; Public Health Schools; Radiation; Recruitment Activity; Reporting; Research; Research Activity; Research Project Grants; Research Support; Resource Sharing; Resources; SECTM1 gene; Schools; Science; Scientist; Seasons; Secure; Source; Surgical Oncology; Training; Training Programs; Translational Research; Treatment-Related Cancer; Underrepresented Minority; Underserved Population; Universities; anticancer research; base; cancer therapy; career; career development; design; drug discovery; experience; instrument; interest; medical schools; meetings; multidisciplinary; multimodality; population based; pre-clinical; professor; programs; success; treatment strategy

DESCRIPTION (provided by applicant): The University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) Paul Calabresi Clinical Oncology Training Program will support career development and training of Calabresi Scholars in clinical oncology translational research. UMGCC Calabresi Scholars will have an M.D., D.O., or equivalent clinical degree, have finished clinical training, and be ready for a junior faculty appointment. In addition, Ph.D.s, Pharm.D.s, or R.N.s with a Ph.D. who have finished at least one post-doctoral experience and who are committing to a career in clinical oncology translational research are eligible. The themes to be promoted in the UMGCC Scholars Program reflect areas of UMGCC strength: multimodality treatment strategies for cancer; drug discovery and development; and clinical cancer research in underserved minority populations. The Program will provide a didactic learning experience leading to a Master of Science in Clinical Research; a clinical research experience that will focus each Scholar's development of a cancer therapy - related clinical trial to answer a hypothesis-based clinical research question with translational endpoints; and a basic/population science activity which will tie to the clinical protocol translational question. The Scholars will be assisted in these goals by each Scholar having a Mentorship Committee consisting of a Clinical Mentor, a Basic/Population Science Mentor, and a Biostatistical Mentor. In addition, an independent Grant Application Development Committee will be formed for each Scholar, unrelated to the Scholar's Mentor Committee, to promote success of the Scholar in securing independent, peer reviewed funding. The UMGCC Program is distinguished by a number of features including 1) participation and support from six professional Schools at the University of Maryland, Baltimore (UMB Schools of Medicine, Pharmacy, Nursing, Dental, Law and the newly formed UMB School of Public Health); 2) experienced, well-funded multidisciplinary mentors; 3) the strength of UMs existing K30 Clinical Research Curriculum for the Calabresi Scholars' didactic training; 4) close coordination and the sharing of resources with existing K12s, particularly the UM Multidisciplinary Clinical Research Career Development Award; 5) a clinical research base consisting of >150 open and accruing clinical trials reflecting multidisciplinary clinical expertise and Institutional commitment to support clinical research.

描述（由申请人提供）：马里兰州玛琳大学和斯图尔特·格林鲍姆癌症中心（UMGCC）Paul Calabresi临床肿瘤学培训计划将支持Calabresi临床肿瘤转化研究中的Calabresi学者的职业发展和培训。 UMGCC Calabresi学者将拥有医学博士学位，D.O。或同等临床学位，已完成临床培训，并准备好任命初级教师。此外，具有博士学位的博士学位，Pharm.D.S或R.N.他们至少完成了一种博士后经验，并且承诺从事临床肿瘤学转化研究职业。在UMGCC学者计划中要促进的主题反映了UMGCC力量的领域：癌症的多模式治疗策略；药物发现和发育；以及在服务不足的少数群体中的临床癌症研究。该计划将提供导致临床研究科学硕士学位的教学经验；临床研究经验将集中于每个学者的癌症治疗 - 相关临床试验，以回答基于假设的临床研究问题，并具有转化终点；以及基本的/人口科学活动，将与临床方案翻译问题联系起来。每个学者将通过由临床指导，基础/人口科学导师和生物统计学导师组成的指导委员会的每个学者来协助这些目标。此外，将为每个学者组建一个独立的赠款申请开发委员会，与学者的导师委员会无关，以促进学者在确保独立的，同行评审的资金方面的成功。 UMGCC计划的特点是许多功能，包括1）马里兰大学六所专业学校的参与和支持（UMB医学，药房，护理，护理，牙科，法律和新成立的UMB公共卫生学院）； 2）经验丰富的多学科导师； 3）UMS现有的K30临床研究课程的强度，用于Calabresi学者的教学培训； 4）与现有K12的密切协调和资源共享，特别是UM多学科临床研究职业发展奖； 5）一个临床研究基础，包括> 150个开放和应计的临床试验，反映了多学科临床专业知识和机构承诺支持临床研究。